Author:
Zhu Jing-Yang,Tang Mei,Li Hu,Shi Yu-Long,Li Yi-Ming,Li Ying-Hong,Ma Xi-Can,Duan Qiong-Lu,Mei Yu-Heng,He Hong-Wei,Zhang Na,Peng Zong-Gen,Song Dan-Qing
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference25 articles.
1. Non-alcoholic fatty liver disease;Powell;Lancet,2021
2. Metabolic-associated fatty liver disease and lipoprotein metabolism;Heeren;Mol. Metab.,2021
3. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans;Pafili;Mol. Metab.,2021
4. Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD). Pathophysiology of NASH in endocrine diseases;Flessa;J. Cell. Biochem.,2022
5. Treating inflammation to combat non-alcoholic fatty liver disease;Wiering;J. Endocrinol.,2022